东瑞制药(02348.HK)8月22日举行董事会会议考虑及批准中期业绩

Core Viewpoint - Dongrui Pharmaceutical (02348.HK) announced that it will hold a board meeting on August 22, 2025, to consider and approve the interim results for the six months ending June 30, 2025, and to discuss the potential declaration of an interim dividend, if any [1] Group 1 - The board meeting is scheduled for August 22, 2025 [1] - The meeting will focus on the interim results for the six months ending June 30, 2025 [1] - The company will also consider the declaration of an interim dividend during the meeting [1]